Skip to Main Content

Paper Details

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses.
NPJ Breast Cancer
6
2021
BRCA1, BRCA1 and BRCA2 tumours, BRCA2, BRCA2 PTVs, HR, PALB2, PALB2 PTVs, PALB2 tumours, RNA, TP53, breast cancer, deficiencies in homologous recombination, patients, tumour, tumours
Author NameAffiliation
Alison M DunningUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Carlos CaldasCambridge Institute & Department of Oncology
Carlos CaldasCambridge Breast Cancer Research Unit, CRUK Cambridge Cancer Centre
Carlos CaldasNIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospital NHS Foundation Trust
  • 1 - 6

Datasets

Release 1.2